FHC
PFE icon

First Heartland Consultants’s Pfizer PFE Stock Holding History

First Heartland Consultants’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$309K Sell
12,834
-309
-2% -$8.08K 0.02% 457
2026
Q1 		$369K Buy
13,143
+220
+2% +$5.86K 0.03% 354
2025
Q4 		$322K Buy
12,923
+781
+6% +$19.7K 0.02% 403
2025
Q3 		$309K Sell
12,142
-67
-0.5% -$1.65K 0.03% 397
2025
Q2 		$296K Sell
12,209
-1,577
-11% -$36.8K 0.03% 391
2025
Q1 		$349K Sell
13,786
-102
-0.7% -$2.67K 0.04% 312
2024
Q4 		$368K Sell
13,888
-1,972
-12% -$53.5K 0.04% 299
2024
Q3 		$459K Buy
15,860
+449
+3% +$13.1K 0.05% 259
2024
Q2 		$431 Sell
15,411
-375
-2% -$10.3K 0.03% 289
2024
Q1 		$438K Buy
15,786
+2,773
+21% +$76.9K 0.05% 269
2023
Q4 		$375K Buy
13,013
+3,933
+43% +$119K 0.05% 255
2023
Q3 		$301K Sell
9,080
-496
-5% -$17.5K 0.04% 286
2023
Q2 		$351K Sell
9,576
-513
-5% -$20K 0.05% 258
2023
Q1 		$412K Buy
10,089
+461
+5% +$19.9K 0.06% 231
2022
Q4 		$493K Sell
9,628
-83
-0.9% -$3.98K 0.08% 199
2022
Q3 		$424 Sell
9,711
-1,737
-15% -$84.4K 0.04% 206
2022
Q2 		$600K Sell
11,448
-39
-0.3% -$1.99K 0.09% 165
2022
Q1 		$594K Sell
11,487
-232
-2% -$12K 0.09% 165
2021
Q4 		$692 Buy
11,719
+59
+0.5% +$2.92K 0.03% 150
2021
Q3 		$502K Sell
11,660
-4,309
-27% -$191K 0.08% 203
2021
Q2 		$625K Sell
15,969
-7,552
-32% -$294K 0.09% 173
2021
Q1 		$852K Buy
23,521
+2,441
+12% +$86.7K 0.14% 139
2020
Q4 		$776K Buy
21,080
+1,227
+6% +$45K 0.13% 120
2020
Q3 		$691K Buy
19,853
+1,352
+7% +$47.4K 0.13% 119
2020
Q2 		$574K Buy
18,501
+6,091
+49% +$207K 0.11% 143
2020
Q1 		$384K Buy
12,410
+263
+2% +$8.96K 0.1% 153
2019
Q4 		$452K Buy
12,147
+95
+0.8% +$3.38K 0.09% 183
2019
Q3 		$411K Buy
12,052
+296
+3% +$10.8K 0.09% 183
2019
Q2 		$483K Sell
11,756
-1,489
-11% -$59.1K 0.12% 157
2019
Q1 		$534K Buy
13,245
+134
+1% +$5.37K 0.15% 138
2018
Q4 		$543K Sell
13,111
-614
-4% -$25.5K 0.2% 115
2018
Q3 		$574K Sell
13,725
-1,372
-9% -$52.8K 0.18% 121
2018
Q2 		$520K Sell
15,097
-5,248
-26% -$179K 0.18% 127
2018
Q1 		$685K Buy
20,345
+1,494
+8% +$51.4K 0.21% 118
2017
Q4 		$648K Sell
18,851
-22,445
-54% -$765K 0.2% 123
2017
Q3 		$1.4M Buy
41,296
+2,540
+7% +$81.6K 0.34% 78
2017
Q2 		$1.24M Buy
38,756
+882
+2% +$27.8K 0.32% 84
2017
Q1 		$1.23M Sell
37,874
-284
-0.7% -$8.95K 0.34% 78
2016
Q4 		$1.18M Sell
38,158
-661
-2% -$20.2K 0.36% 77
2016
Q3 		$1.25M Buy
38,819
+1,492
+4% +$49.9K 0.36% 70
2016
Q2 		$1.25K Buy
37,327
+5,290
+17% +$169K 0.14% 61
2016
Q1 		$901K Buy
32,037
+2,106
+7% +$60.2K 0.34% 72
2015
Q4 		$917K Buy
29,931
+226
+0.8% +$7.11K 0.35% 77
2015
Q3 		$885K Sell
29,705
-52
-0.2% -$1.67K 0.37% 70
2015
Q2 		$947 Sell
29,757
-570
-2% -$18.6K 0.26% 75
2015
Q1 		$1M Sell
30,327
-256
-0.8% -$8.14K 0.38% 72
2014
Q4 		$904K Sell
30,583
-1,156
-4% -$33.1K 0.37% 74
2014
Q3 		$890K Buy
31,739
+1,162
+4% +$32.6K 0.39% 74
2014
Q2 		$861K Buy
30,577
+4,667
+18% +$133K 0.39% 80
2014
Q1 		$790K Buy
25,910
+768
+3% +$22.9K 0.39% 74
2013
Q4 		$731K Buy
25,142
+622
+3% +$18.1K 0.41% 74
2013
Q3 		$672K Buy
24,520
+2,688
+12% +$73.1K 0.41% 71
2013
Q2 		$580K Buy
+21,832
New +$603K 0.34% 78

Other funds holding PFE

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
WG
Welch Group Birmingham, Alabama $2.93B AUM 27.62% 1-Year Est. Return

First Heartland Consultants's PFE Position: Q2 2026 in Review

First Heartland Consultants reduced its Pfizer (PFE) stake by 2.4% in Q2 2026, selling an estimated $8.08K and leaving 12,834 shares worth $309K. The position accounts for 0.02% of the portfolio, ranked #457.

First Heartland Consultants first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.4M in Q3 2017. 900 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • First Heartland Consultants held 12,834 shares of Pfizer worth $309K as of Q2 2026.
  • First Heartland Consultants sold 309 Pfizer shares in Q2 2026, an estimated $8.08K.
  • Pfizer made up 0.02% of First Heartland Consultants's portfolio in Q2 2026, its #457 holding.
  • First Heartland Consultants first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
  • First Heartland Consultants's Pfizer position peaked at $1.4M in Q3 2017.
  • 900 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on First Heartland Consultants's 13F filing for Q2 2026, filed 8 Jul 2026.